PATIENT INFORMATION LEAFLET
Viaflo Glucose 5% and Sodium Chloride 0.9% Infusion Solution
Active ingredient: glucose, sodium chloride
Read this leaflet carefully before you start using this medicine because it contains important information for you.
This medicine is called “Viaflo Glucose 5% and Sodium Chloride 0.9% Infusion Solution”, but it will be referred to as “Viaflo Glucose 5% and Sodium Chloride 0.9%” in the rest of this leaflet.
Glucose is one of the body's energy sources. This solution provides 200 kilocalories per liter. Sodium and chloride are chemical substances found in the blood.
Viaflo Glucosa 5% and sodium chloride 0.9% is used:
You should not receive Viaflo Glucosa 5% and Cloruro sódico 0.9% in the following cases:
Warnings and precautions
Inform your doctor if you have or have had any of the following clinical situations:
This may increase the risk of having low sodium levels in the blood and may cause headache, nausea, convulsions, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
Conditions associated with sodium retention, fluid overload, and edema, such as:
The infusion may cause:
When you receive this infusion, your doctor will be able to take blood and urine samples to control:
As Viaflo Glucosa 5% and Cloruro sódico 0.9% contains sugar (glucose), it may increase blood sugar (hyperglycemia). If this occurs, your doctor will be able to:
This is particularly important:
Your doctor should take into account if you are receiving parenteral nutrition (nutrition administered through an intravenous infusion in a vein). During prolonged treatments with Viaflo Glucosa 5% and Cloruro sódico 0.9%, you may need to receive additional nutrition. Your doctor should also monitor your potassium levels in the blood to avoid them decreasing too much (hypokalemia).
Children
Special care should be taken when administering this solution to children, babies, and newborns (especially premature babies and those with low birth weight) as they may not have a good ability to handle the chemical substances in the solution.
Newborns - especially premature babies and those with low birth weight - are at higher risk of developing low or high blood sugar levels (hypoglycemia or hyperglycemia) and therefore require careful monitoring during treatment with intravenous solutions containing glucose to ensure proper control of blood sugar levels to avoid potential long-term adverse effects. Low blood sugar levels in newborns can cause prolonged convulsions, coma, and brain damage. High blood sugar levels can cause cerebral hemorrhage, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections (necrotizing enterocolitis), respiratory problems (bronchopulmonary dysplasia), prolonged hospital stay, and death.
Children are at higher risk of having or developing low sodium levels in the blood (hyponatremia). Hyponatremia can cause headache, nausea, convulsions, lethargy, coma, brain inflammation (cerebral edema), and death. Acute hyponatremic encephalopathy is a serious complication, especially in children. Your doctor knows all this and will carefully monitor the amount of chemical substances, such as sodium and chloride, in your child's blood (plasma electrolytes)
Other medications and Viaflo Glucosa 5% and Cloruro sódico 0.9%
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
It is particularly important to inform your doctor if you are taking:
These medications can cause the body to accumulate sodium and water, leading to:
Some medications act on the vasopressin hormone. These may include:
Other medications that may affect or be affected by Viaflo Glucosa 5% and Cloruro sódico 0.9%:
Viaflo Glucosa 5% and Cloruro sódico 0.9% should not be administered through the same needle as used in a blood transfusion, as it may damage red blood cells or cause them to clump.
Use of Viaflo Glucosa 5% and Cloruro sódico 0.9% with food and drinksandbeverages
Ask your doctor about what you can eat or drink.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or nurse before using a medication.
Viaflo Glucosa 5% and Cloruro sódico 0.9% can be administered during breastfeeding.
If another medication is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Viaflo Glucosa 5% and Cloruro sódico 0.9% does not affect your ability to drive or use machines.
Infusion of Glucose 5% and Sodium Chloride 0.9% will be administered by a doctor or nurse. Your doctor will decide how much you need and when to administer it. This will depend on your age, weight, physical condition, and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
DO NOT receive Glucose 5% and Sodium Chloride 0.9% if there are particles floating in the solution or if the container is damaged in any way.
Glucose 5% and Sodium Chloride 0.9% will usually be administered through a plastic tube connected to a needle inserted into a vein. However, your doctor may administer the medication in another way.
Any unused solution should be discarded. DO NOT receive Glucose 5% and Sodium Chloride 0.9% from a bag that has been partially used.
Before and during the infusion, your doctor will monitor:
If you are administered more Glucose 5% and Sodium Chloride 0.9% than you should
If you receive too much of the Glucose 5% and Sodium Chloride 0.9% solution or if the administration is too rapid, you may experience the following symptoms:
If you develop any of these symptoms,inform your doctor immediately.The infusion will be stopped and you will receive treatment based on the symptoms.
If a medication has been added to Glucose 5% and Sodium Chloride 0.9% before the excessive administration, the medication may also cause symptoms. Please read the list of possible symptoms in the medication's package insert.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone: 91 562 04 20.
Stopping the infusion ofGlucose 5% and Sodium Chloride 0.9%
Your doctor will decide when to stop receiving this infusion.
If you have any other questions about the use of this product, ask your doctor or nurse.
Like all medications, this medication may produce adverse effects, although not all people will experience them.
Adverse effects may be related to Viaflo Glucose 5% and Sodium Chloride 0.9%. These include:
Adverse effects maymay be due tothe administration technique. This includes:
If a medication has been added to the infusion solution, it may also produce adverse effects. These adverse effects will depend on the added medication. You should read the list of possible symptoms in the prospectus of the added medication.
Reporting Adverse Effects:
If you experience any type of adverse effect, consult your doctor or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Viaflo Glucose 5% and Sodium Chloride 0.9% does not require special conditions for conservation.
Viaflo Glucose 5% and Sodium Chloride 0.9% should not be administered after the expiration date that appears on the bag after CAD. The expiration date is the last day of the month indicated.
Viaflo Glucose 5% and Sodium Chloride 0.9% should not be received if there are particles floating in the solution or if the container is damaged in any way.
Composition of Viaflo Glucose 5% and Sodium Chloride 0.9%
The active principles are
The other component is water for injection preparations.
Appearance of the product and contents of the container
Viaflo Glucose 5% and Sodium Chloride 0.9% is a transparent, particle-free solution. It is presented in polyolefin/polyamide (Viaflo) plastic bags. Each bag is packaged in a sealed plastic protective overbag.
The bag sizes are:
The bags are supplied in boxes, each containing the following quantities:
Only some sizes of containers may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder
Baxter S.L.
Camilo Pouet Street, 2
46394, Ribarroja del Turia (Valencia)
Responsible for manufacturing:
Bieffe Medital S.A.
Biescas Road, Senegüé
22666 Sabiñanigo (Huesca)
Spain
Baxter SA
René Branquart Boulevard, 80
7860 Lessines
Belgium
Last review date of this prospectus: October 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
This information is intended solely for healthcare professionals
Handling and preparation
Use only if the solution is transparent, free of visible particles, and the container is not damaged. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its protective overbag until it is ready for use.
The inner bag maintains the sterility of the product.
Do not connect in series plastic containers. This type of connection may cause gas embolism due to residual air carried from the primary container before the secondary container is fully administered.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates may lead to gas embolism if the residual air in the container is not fully evacuated before administration.
The use of an intravenous administration equipment with a ventilation filter in open position may cause gas embolism. This type of intravenous administration equipment with the ventilation filter in open position should not be used with flexible plastic containers.
The solution must be administered with a sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air entry into the system.
Medicines may be introduced before or during infusion through the resuable medication port.
When adding medicines, verify isotonicity before parenteral administration. A complete and careful aseptic mixing of any added medicine is required. Solutions containing added medicines must be used immediately and should not be stored.
Pediatric population
To avoid a potentially fatal overdose during intravenous infusion of solutions in newborns, special attention should be paid to the administration method. When using a syringe pump to administer liquids or medicines intravenously to newborns, do not leave a solution bag connected to the syringe.
When using an infusion pump, all clamps of the intravenous administration equipment must be closed before removing the administration equipment from the pump or disconnecting the pump. This is required regardless of whether the administration equipment has a free-flow device.
The intravenous infusion equipment and administration equipment must be controlled frequently.
Discard after single use
Discard any remaining portion.
Do not reconnect partially used bags.
1-To open
a-Remove the Viaflo bag from the protective overbag immediately before use.
b-Check for small leaks by pressing the inner bag firmly. If leaks are detected, discard the solution, as it may not be sterile.
c-Check the transparency of the solution and the absence of foreign particles. Discard the solution if it is not transparent or contains foreign particles.
2-Preparation for administration
Use sterile material for preparation and administration.
a-Hang the container by the hanger
b-Remove the plastic protector from the outlet port at the bottom of the container.
-hold one hand on the small handle of the neck of the outlet port.
-hold the other hand on the large handle of the closure cap and turn.
-the cap will come off.
c-Use an aseptic technique to prepare the infusion
d-Connect the administration equipment. Consult the instructions accompanying the equipment for its connection, priming, and administration of the solution.
3-Techniques for injecting added medication
Warning: Added medicines may be incompatible (see section 5 "Incompatibilities of added medicines" below).
To add medication before administration.
aDisinfect the medication port
bUsing a syringe with a 19 G (1.10 mm) to 22 G (0.70 mm) needle, puncture the resuable medication port and inject.
cMix the medication and solution carefully. For high-density medicines, such as potassium chloride, gently move the tubes while in vertical position and mix.
Caution: Do not store bags with added medication.
To add medication during administration
aClose the clamp of the equipment
bDisinfect the medication port
cUsing a syringe with a 19 G (1.10 mm) to 22 G (0.70 mm) needle, puncture the resuable medication port and inject.
dRemove the container from the IV stand and/or turn it to a vertical position.
eEmpty both tubes by gently tapping them while the container is in vertical position
fMix the solution and medication carefully
gReturn the container to its original position, reopen the clamp, and continue administration
4.Expiry in use (added medicines)
Before use, the physical and chemical stability of any additional medication to the pH of the Viaflo Glucose 5% and Sodium Chloride 0.9% solution in the Viaflo container must be established.
From a microbiological point of view, the diluted product must be used immediately. If not used immediately, the conditions and storage period before use are the responsibility of the user and are normally not greater than 24 hours at 2-8°C, unlessthe reconstitution was performed in controlled and validated aseptic conditions.
5-Incompatibilities of added medicines
As with all parenteral solutions, the compatibility of added medicines to the solution in the Viaflo bag must be verified before addition.
It is the responsibility of the doctor to judge the incompatibility of the added medicine to Viaflo Glucose 5% and Sodium Chloride 0.9% by examining any eventual change in color and/or precipitation, insoluble complexes, or appearance of crystals. The prospectus of the medicine to be added should be consulted.
Before adding a medicine, verify that it is soluble and stable in water at the pH of the Viaflo Glucose 5% and Sodium Chloride 0.9% solution (pH 3.5 to 6.5).
When adding a compatible medicine to Viaflo Glucose 5% and Sodium Chloride 0.9%, the solution must be used immediately.
As a guideline, the following medicines are incompatible with Viaflo Glucose 5% and Sodium Chloride 0.9% (non-exhaustive list):
- Sodium ampicillin
- Mitomycin
- Amphotericin B
- Erythromycin lactobionate.
Due to the presence of glucose, Viaflo Glucose 5% and Sodium Chloride 0.9% should not be administered through the same infusion equipment as whole blood, as it may cause hemolysis and agglutination.
Medicines that are known to be incompatible should not be used.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.